Polar Asset Management Partners’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-250,000
Closed -$11.5K 1195
2023
Q1
$11.5K Hold
250,000
﹤0.01% 959
2022
Q4
$2.67K Hold
250,000
﹤0.01% 1174
2022
Q3
$23K Hold
250,000
﹤0.01% 1150
2022
Q2
$32K Hold
250,000
﹤0.01% 1128
2022
Q1
$70K Hold
250,000
﹤0.01% 934
2021
Q4
$122K Buy
+250,000
New +$126K ﹤0.01% 1102

Polar Asset Management Partners's IQMDW Position: Q2 2023 in Review

Polar Asset Management Partners sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 250,000 shares — an estimated $11.5K sold.

Polar Asset Management Partners first reported a position in IQMDW in Q4 2021 and held it in 6 quarters. The position peaked at $122K in Q4 2021. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

  • Polar Asset Management Partners reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
  • Polar Asset Management Partners sold 250,000 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $11.5K.
  • Polar Asset Management Partners first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q4 2021 and held it in 6 quarters.
  • Polar Asset Management Partners's Intelligent Medicine Acquisition Corp. Warrant position peaked at $122K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Polar Asset Management Partners's 13F filing for Q2 2023, filed 14 Aug 2023.